PUBLISHER: The Business Research Company | PRODUCT CODE: 2082211
PUBLISHER: The Business Research Company | PRODUCT CODE: 2082211
Over-the-counter (OTC) veterinary drugs are medications available for purchase without a prescription from a licensed veterinarian and are intended for the treatment, prevention, or management of common animal health conditions. These drugs are regarded as safe and effective for use by animal owners when administered according to the instructions provided on the label.
The primary product types of over-the-counter (OTC) veterinary drugs include antiparasitics, anti infectives, analgesics and anti inflammatory drugs, nutritional supplements, dermatological products, vaccines, and other product types. Antiparasitics refer to veterinary medicines utilized to prevent and control internal and external parasites in animals to maintain overall health. The different animal types include companion animals, livestock and production animals, and equine, and the various formulation types include tablets, liquids, powders, topical formulations, injectables, and other formulation types. They are utilized through sales channels including hospital pharmacies, retail pharmacies, drug stores, and e-commerce, and the various applications involved include infection treatment, parasitic control, pain management, nutritional support, skin and coat care, and other applications.
Tariffs are affecting the over-the-counter (OTC) veterinary drugs market by increasing the cost of imported active pharmaceutical ingredients, veterinary formulations, and feed-grade additives used in animal healthcare products. This is disrupting supply chains and increasing retail prices, particularly in regions dependent on imports such as Asia-Pacific and Latin America. Segments including antiparasitics, anti-infectives, and nutritional supplements are most impacted due to significant dependence on global raw material sourcing and manufacturing hubs. However, tariffs are also supporting local production of veterinary pharmaceuticals, strengthening domestic supply chains, and encouraging regional manufacturing investments, which enhance long-term market resilience and accessibility of OTC animal health products.
The over-the-counter (OTC) veterinary drugs market research report is one of a series of new reports from The Business Research Company that provides over-the-counter (OTC) veterinary drugs market statistics, including over-the-counter (OTC) veterinary drugs industry global market size, regional shares, competitors with a over-the-counter (OTC) veterinary drugs market share, detailed over-the-counter (OTC) veterinary drugs market segments, market trends and opportunities, and any further data you may need to thrive in the over-the-counter (OTC) veterinary drugs industry. This over-the-counter (OTC) veterinary drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The over-the-counter (OTC) veterinary drugs market size has grown strongly in recent years. It will grow from $8.93 billion in 2025 to $9.7 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing pet ownership rates, rising livestock population globally, growth in veterinary pharmaceutical availability in retail channels, increasing awareness of animal health and hygiene, expansion of animal healthcare infrastructure in rural regions.
The over-the-counter (OTC) veterinary drugs market size is expected to see strong growth in the next few years. It will grow to $13.57 billion by 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to rising demand for preventive animal healthcare solutions, increasing adoption of e-commerce veterinary drug sales, growth in companion animal healthcare spending, expansion of nutraceutical and supplement-based veterinary care, rising focus on antimicrobial resistance reduction through OTC alternatives. Major trends in the forecast period include rising adoption of over the counter antiparasitic and anti infective veterinary drugs for easy livestock and companion animal care, increasing demand for nutraceutical based OTC veterinary supplements supporting immunity and joint health, growing preference for dermatological OTC animal care products for skin and coat management, expansion of e-commerce platforms enabling direct access to veterinary OTC medicines, rising use of broad spectrum OTC formulations for preventive animal health management.
The increasing rates of pet ownership are expected to drive the growth of the over-the-counter (OTC) veterinary drugs market going forward. Pet ownership rates refer to the percentage or proportion of households or individuals owning one or more pets within a particular population or geographic area. Rising pet ownership rates are driven by growing companionship needs, as more individuals seek emotional support, comfort, and a sense of connection through pets in their everyday lives. Increasing pet ownership rates result in higher demand for over-the-counter (OTC) veterinary drugs, as more pet owners look for convenient and cost-effective solutions for routine pet healthcare management and preventive care. For instance, in March 2025, according to the American Pet Products Association (APPA), a US-based trade association, the number of U. S. households owning at least one pet increased from 82 million in 2023 to 94 million. Therefore, the increasing rates of pet ownership are driving the growth of the over-the-counter (OTC) veterinary drugs market.
Leading companies operating in the over-the-counter (OTC) veterinary drugs market are focusing on technological advancements in animal healthcare, such as science-backed, veterinarian-formulated supplement systems, to gain a competitive advantage. This technology utilizes advanced nutraceutical formulations and clinically studied ingredients to support preventive care and chronic-condition management in companion animals through non-prescription oral products. For instance, in February 2025, Elanco Animal Health, a US-based animal health company, launched Pet Protect, a veterinarian-formulated supplement line for dogs and cats that includes fast-acting calming chews, joint-health and skin-health formulations, as well as multivitamin and omega-3 blends designed to address common wellness needs. Pet Protect incorporates species-specific palatability engineering, proprietary ingredient blends, and transparent, evidence-driven labeling, thereby strengthening Elanco's presence in the OTC veterinary supplement segment while aligning with pet owners' demand for convenient at-home wellness solutions.
In April 2023, PetMed Express Inc., a US-based online pharmacy company, acquired PetCareRx Inc. for an undisclosed amount. Through this acquisition, PetMeds aims to strengthen its position in the online pet pharmacy market by expanding its product portfolio, reaching a broader customer base, and improving operational efficiency and customer engagement. PetCareRx Inc. is a US-based pet health and wellness company that offers a range of over-the-counter (OTC) pet medications.
Major companies operating in the over-the-counter (otc) veterinary drugs market are Merck And Co Inc, Boehringer Ingelheim Animal Health GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Limited, Ceva Sante Animale, Virbac S. A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Laboratorios Hipra S. A., Vetoquinol S. A., Indian Immunologicals Limited, Sequent Scientific Limited, Ourofino Saude Animal, Bioveta A. S, Huvepharma EOOD, Ashish Life Science Private Limited, Zydus Animal Health and Investments Limited, Norbrook Laboratories Limited, Kyoritsu Seiyaku Corporation
North America was the largest region in the over-the-counter (OTC) veterinary drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over-the-counter (OTC) veterinary drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the over-the-counter (OTC) veterinary drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The over-the-counter (OTC) veterinary drugs market consists of sales of dewormers, ear care products, eye care products, oral care (dental) products, and wound care and antiseptic products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Over-The-Counter (OTC) Veterinary Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses over-the-counter (otc) veterinary drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for over-the-counter (otc) veterinary drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The over-the-counter (otc) veterinary drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.